Nilgün Karalı

1.2k total citations
63 papers, 1.0k citations indexed

About

Nilgün Karalı is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Nilgün Karalı has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Organic Chemistry, 17 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Nilgün Karalı's work include Synthesis and biological activity (37 papers), Synthesis and Characterization of Heterocyclic Compounds (18 papers) and Synthesis and Reactions of Organic Compounds (11 papers). Nilgün Karalı is often cited by papers focused on Synthesis and biological activity (37 papers), Synthesis and Characterization of Heterocyclic Compounds (18 papers) and Synthesis and Reactions of Organic Compounds (11 papers). Nilgün Karalı collaborates with scholars based in Türkiye, Italy and Belgium. Nilgün Karalı's co-authors include Aysel Gürsoy, Özlen Güzel-Akdemir, Aydın Salman, Süheyla Özbey, Nurten Özsoy, Claudiu T. Supuran, Atilla Akdemir, F.B. Kaynak, Nalan Terzioğlu and Anatholy Dimoglo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and European Journal of Medicinal Chemistry.

In The Last Decade

Nilgün Karalı

59 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilgün Karalı Türkiye 18 864 330 135 112 77 63 1.0k
Akranth Marella India 13 1.0k 1.2× 310 0.9× 141 1.0× 129 1.2× 133 1.7× 21 1.3k
Şeref Demirayak Türkiye 19 1.1k 1.3× 291 0.9× 190 1.4× 104 0.9× 132 1.7× 79 1.3k
Shamsuzzaman India 16 635 0.7× 319 1.0× 111 0.8× 93 0.8× 65 0.8× 40 1.0k
Matúš Peško Slovakia 19 626 0.7× 345 1.0× 85 0.6× 76 0.7× 61 0.8× 45 866
Aysel Gürsoy Türkiye 17 1.2k 1.4× 260 0.8× 128 0.9× 143 1.3× 53 0.7× 37 1.3k
Massimiliano Granaiola Italy 18 997 1.2× 290 0.9× 155 1.1× 77 0.7× 96 1.2× 31 1.2k
Abdel-Rahman B.A. El-Gazzar Egypt 20 1.6k 1.8× 286 0.9× 136 1.0× 78 0.7× 64 0.8× 59 1.7k
Mahesh B. Palkar India 20 864 1.0× 322 1.0× 159 1.2× 54 0.5× 64 0.8× 49 1.1k
Gricela Lobo Venezuela 11 707 0.8× 302 0.9× 135 1.0× 53 0.5× 55 0.7× 25 960
Kishor H. Chikhalia India 22 1.6k 1.8× 315 1.0× 106 0.8× 60 0.5× 67 0.9× 134 1.7k

Countries citing papers authored by Nilgün Karalı

Since Specialization
Citations

This map shows the geographic impact of Nilgün Karalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilgün Karalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilgün Karalı more than expected).

Fields of papers citing papers by Nilgün Karalı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilgün Karalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilgün Karalı. The network helps show where Nilgün Karalı may publish in the future.

Co-authorship network of co-authors of Nilgün Karalı

This figure shows the co-authorship network connecting the top 25 collaborators of Nilgün Karalı. A scholar is included among the top collaborators of Nilgün Karalı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilgün Karalı. Nilgün Karalı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karalı, Nilgün, et al.. (2025). 2‐Indolinone: An Anticancer Scaffold, Overview of the Studies and Approaches (2017–2024). ChemistrySelect. 10(5). 1 indexed citations
2.
Öztay, Füsun, et al.. (2025). New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors. Bioorganic Chemistry. 156. 108203–108203. 1 indexed citations
3.
Özsoy, Nurten, et al.. (2024). Synthesis and Molecular Docking Studies of 5-Trifluoromethoxy-2-Indolinones as Cholinesterase Dual Inhibitors. Future Medicinal Chemistry. 16(7). 623–645. 3 indexed citations
4.
Özkırımlı, Elif, et al.. (2024). Exploring data‐driven chemical SMILES tokenization approaches to identify key protein–ligand binding moieties. Molecular Informatics. 43(3). e202300249–e202300249. 2 indexed citations
5.
Naesens, Lieve, et al.. (2024). Novel 2-Indolinone Derivatives as Promising Agents against Respiratory Syncytial and Yellow Fever Viruses. Future Medicinal Chemistry. 16(4). 295–310. 1 indexed citations
6.
Şenol, Halil, et al.. (2024). Bioisosteric replacement of the carboxylic acid group in Hepatitis-C virus NS5B thumb site II inhibitors: phenylalanine derivatives. European Journal of Medicinal Chemistry. 279. 116832–116832. 5 indexed citations
7.
Karalı, Nilgün, et al.. (2023). Bioisosterism: 1,2,4‐Oxadiazole Rings. ChemMedChem. 18(9). e202200638–e202200638. 23 indexed citations
8.
Özbil, Mehmet, et al.. (2023). Antiviral activity and molecular modeling studies on 1H-indole-2,3-diones carrying a naphthalene moiety. Journal of Molecular Structure. 1281. 135100–135100. 4 indexed citations
9.
Lack, Nathan A., et al.. (2023). 5‐Fluoro/(trifluoromethoxy)‐2‐indolinone derivatives with anti‐interleukin‐1 activity. Archiv der Pharmazie. 356(12). e2300217–e2300217. 3 indexed citations
10.
Karalı, Nilgün, et al.. (2022). A Mini-Review on the Synthesis of Substituted Isatins: From Early Approachesto Recent Advances with a Specific Focus on Sulfamoyl andAmino Derivatives. Mini-Reviews in Organic Chemistry. 21(1). 58–72. 1 indexed citations
11.
Akdemir, Atilla, et al.. (2022). New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors. Archiv der Pharmazie. 355(8). e2200023–e2200023. 6 indexed citations
12.
Özsoy, Nurten, et al.. (2022). Synthesis and Molecular Modeling Studies of 1-Benzyl-2-Indolinones As Selective AChE Inhibitors. Future Medicinal Chemistry. 14(23). 1705–1723. 4 indexed citations
13.
Karalı, Nilgün, et al.. (2021). Histone deacetylase inhibitors providing an epigenetic treatment in cancer. Istanbul Journal of Pharmacy. 51(2). 283–290.
14.
Akgün‐Dar, Kadriye, et al.. (2021). Selective Cytotoxic Effects of 5-Trifluoromethoxy-1H-indole-2,3-dione 3-ThiosemicarbazoneDerivatives on Lymphoid-originated Cells. Anti-Cancer Agents in Medicinal Chemistry. 22(2). 349–355. 1 indexed citations
15.
Özsoy, Nurten, et al.. (2021). Synthesis, Molecular Modeling and Cholinesterase Inhibitory Effects of 2-Indolinone-Based Hydrazinecarbothioamides. Future Medicinal Chemistry. 13(24). 2133–2151. 6 indexed citations
16.
Cantürk, Zerrin, et al.. (2020). Anticancer and antituberculosis effects of 5-fluoro1H-indole-2,3-dione 3-thiosemicarbazones. Istanbul Journal of Pharmacy. 50(3). 176–180. 2 indexed citations
17.
Karalı, Nilgün, et al.. (2019). Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. Istanbul Journal of Pharmacy. 48(3). 63–67. 5 indexed citations
18.
Karalı, Nilgün, et al.. (2017). (2Z)-2-(5-Fluoro-1-methyl-2-oxoindolin-3-ylidene)-N-(3-fluorophenyl)hydrazine-1-carbothioamide. SHILAP Revista de lepidopterología. 2(6). 3 indexed citations
19.
Karalı, Nilgün, et al.. (2004). Synthesis and antimicrobial activity of some benzazole derivatives. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 43(1). 212–216. 2 indexed citations
20.
Gürsoy, Aysel & Nilgün Karalı. (2003). Synthesis, Characterization and Primary Antituberculosis Activity Evaluation of 4-(3-Coumarinyl)-3-benzyl-4-thiazolin-2-one Benzylidenehydrazones. DergiPark (Istanbul University). 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akranth Marella Breakdown of academic impact, for papers by Şeref Demirayak Breakdown of academic impact, for papers by Shamsuzzaman Breakdown of academic impact, for papers by Matúš Peško Breakdown of academic impact, for papers by Aysel Gürsoy Breakdown of academic impact, for papers by Massimiliano Granaiola Breakdown of academic impact, for papers by Abdel-Rahman B.A. El-Gazzar Breakdown of academic impact, for papers by Mahesh B. Palkar Breakdown of academic impact, for papers by Gricela Lobo Breakdown of academic impact, for papers by Kishor H. Chikhalia
Rankless by CCL
2026